Behavioral pharmacology of the pyrazoloquinoline CGS 9896, a novel putative anxiolytic

This publication has 19 references indexed in Scilit:

• The effects of tofisopam, a 3,4-benzodiazepine, in animal models of anziety, sedation, and convulsions
  Drug Development Research, 1985
• The effects of PK 11195, a ligand for benzodiazepine binding sites, in animal tests of anxiety and stress
  Pharmacology Biochemistry and Behavior, 1985
• Pro- and anti-convulsant drug effects in combination with the convulsant benzodiazepine Ro 5–4864
  Journal of Pharmacy and Pharmacology, 1985
• What can be learned from the effects of benzodiazepines on exploratory behavior?
  Neuroscience & Biobehavioral Reviews, 1985
• The Anxiolytic But Not the Sedative Properties of Tracazolate Are Reversed by the Benzodiazepine Receptor Antagonist, Ro 15-1788
  Neuropsychobiology, 1985
• The effects of the β-carboline FG 7142, on intracranial self-stimulation in the rat
  Pharmacology Biochemistry and Behavior, 1984
• Anti-conflict and depressant effects by GABA agonists and antagonists, benzodiazepines and non-gabergic anticonvulsants on self-stimulation and locomotor activity
  Pharmacology Biochemistry and Behavior, 1983
• CGS 9896, a chloro‐derivative of the diazepam antagonist CGS 8216, exhibits anxiolytic activity in the pentylenetetrazol‐saline discrimination test
  Drug Development Research, 1982
• A novel pyrazoloquinoline that interacts with brain benzodiazepine receptors: Characterization of some and properties of CGS 9896.
  Life Sciences, 1982
• A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants
  Pharmacology Biochemistry and Behavior, 1979